Eurican DAP inj. susp. (lyoph. + solv.) s.c. vial

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Canine Parvovirus (live, attenuated) ; Canine Distemper Virus (live, attenuated) ; Canine Adenovirus 2 (live, attenuated)

Available from:

Boehringer Ingelheim Animal Health Belgium SA-NV

ATC code:

QI07AD02

INN (International Name):

Canine Distemper Virus (CDV); Canine Adenovirus Type 2; Canine Parvovirus Type 2

Pharmaceutical form:

Lyophilisate and solvent for suspension for injection

Composition:

Canine Distemper Virus (CDV); Canine Adenovirus Type 2; Canine Parvovirus Type 2

Administration route:

Subcutaneous use

Therapeutic group:

dog

Therapeutic area:

Canine Distemper Virus + Canine Adenovirus + Canine Parvovirus

Product summary:

CTI code: 499155-01 - Pack size: 10 x 1 dose + 10 x 1 ml - Commercialisation status: YES - FMD code: 03661103053590 - CNK code: 3495041 - Delivery mode: Medical prescription; CTI code: 499155-03 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 499155-02 - Pack size: 50 x 1 dose + 50 x 1 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: Yes

Authorization date:

2016-07-04